Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia is a PHASE2 clinical asset sponsored by Ain Shams University in Transfusion Dependent Beta Thalassemia. SEO and diligence focus: Dulaglutide 0.75Mg/0.5Ml Inj Pen, control group (insulin), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.